Summary
- Current Price
- As of today, EWTX price is $42.76, down -3.24% on
- Current Price All-Time High
- EWTX price is currently -11.65% below its historical high of $48.40 set on
- Market Cap
- EWTX current market cap is $5B, up +200.92% over the past 365 days
- Revenue
- EWTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for EWTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Edgewise Therapeutics, Inc. |
| Ticker | NASDAQ: EWTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | edgewisetx.com |
| Employees | 117 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $42.76 | |
| Price, 1D Change | -3.24% | |
| $5B | ||
| - | ||
| - | ||
| 1.31 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.63 | ||
| EPS, 1Y Change | -12.58% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.63 | ||
| EPS Estimate | $1.38 | N/A |
| EPS Est. Change | +184.67% | N/A |
| $0.00 | ||
| Revenue Estimate | $139.58M | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $42.76 | |
| Price Target | $52.00 | - |
| Price Tgt. Change | +21.61% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.49 | -$1.45 | +3.11% | |
| -$1.60 | -$1.63 | -1.69% | |
| $1.38 | N/A | +184.67% | |
| -$1.82 | N/A | -11.40% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $139.58M | N/A | - | |
| $42.73M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $42.76 | |
| $32.47 | ||
| $41.94 | ||
| $33.47 | ||
| $41.49 | ||
| $0.76 | ||
| 1.31 | ||
| $2.23 | ||
| 48.96 | ||
| 50.49% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.63 | ||
| $0.00 | ||
| - | ||
| -$191.41M | ||
| - | ||
| -$167.80M | ||
| - | ||
| -$189.14M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 19.85 | ||
| 19.85 | ||
| - | ||
| - | ||
| 91.56 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 10.36 | ||
| -19.33 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $522.26M | ||
| $530.11M | ||
| $552.60M | ||
| $543.39M | ||
| $30.35M | ||
| $27.37M | ||
| $3.99M | ||
| $1.01M | ||
| $6.01M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $167.80M | ||
| $189.14M | ||
| $2.27M | ||
| $40.02M | ||
| $2.27M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$143.82M | ||
| -$32.79M | ||
| $196.09M | ||
| $256.00K | ||
| -$144.07M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| JP Morgan | → | |
| Goldman Sachs | → | |
| Evercore ISI Group | → | |
| Oppenheimer | ||
| Guggenheim | → | |
| RBC Capital | → | |
| Goldman Sachs | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
No data
Screeners with EWTX
FAQ
- What is the ticker symbol for Edgewise Therapeutics, Inc.?
- The ticker symbol for Edgewise Therapeutics, Inc. is NASDAQ:EWTX
- Does Edgewise Therapeutics, Inc. pay dividends?
- No, Edgewise Therapeutics, Inc. does not pay dividends
- What sector is Edgewise Therapeutics, Inc. in?
- Edgewise Therapeutics, Inc. is in the Healthcare sector
- What industry is Edgewise Therapeutics, Inc. in?
- Edgewise Therapeutics, Inc. is in the Biotechnology industry
- What country is Edgewise Therapeutics, Inc. based in?
- Edgewise Therapeutics, Inc. is headquartered in United States
- When did Edgewise Therapeutics, Inc. go public?
- Edgewise Therapeutics, Inc. initial public offering (IPO) was on March 26, 2021
- Is Edgewise Therapeutics, Inc. in the S&P 500?
- No, Edgewise Therapeutics, Inc. is not included in the S&P 500 index
- Is Edgewise Therapeutics, Inc. in the NASDAQ 100?
- No, Edgewise Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Edgewise Therapeutics, Inc. in the Dow Jones?
- No, Edgewise Therapeutics, Inc. is not included in the Dow Jones index
- When was Edgewise Therapeutics, Inc. last earnings report?
- Edgewise Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Edgewise Therapeutics, Inc. report earnings?
- The next expected earnings date for Edgewise Therapeutics, Inc. is November 5, 2026
Data Sources & References
- EWTX Official Website edgewisetx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1710072/000110465926020112/0001104659-26-020112-index.htm
- EWTX Profile on Yahoo Finance finance.yahoo.com/quote/EWTX
- EWTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ewtx